TERMS OF USE AND PRIVACY POLICIES
HIPAA Notice of Privacy Practices
Standard Shipping Terms and Conditions
Website Terms of Use
Website Privacy Policy
Please read this Privacy Statement carefully. Privacy is very important to us, and we understand it is also important to you. This Privacy Statement sets out how Adaptive Biotechnologies uses and protects any information that you give Adaptive when you use this website.
Adaptive is committed to ensuring that your privacy is protected. Should we ask you to provide certain information by which you can be identified when using this website, it will only be used in accordance with this Privacy Statement.
This Privacy Statement was last revised on October 26, 2014. Adaptive may occasionally change this policy by updating this page. You should check this page periodically to ensure that you are happy with any changes.
By using this website, you agree to the terms of the most recent version of this Privacy Statement. Please read our Terms of Use to understand the general rules about your use of this website. Except as written in any other disclaimers, polices, terms of use, or other notices in this website, this Privacy Statement and the Terms of Use are the complete agreement between you and Adaptive with respect to your use of this website. You may be subject to additional terms that may apply when you access particular services or material on certain areas in this website, or by following a link from this website.
OUR INTELLECTUAL PROPERTY
Adaptive’s patent portfolio includes the following issued U.S. patents:
- U.S. Patent No. 8,236,503, entitled “Methods of Monitoring Conditions by Sequence Analysis”
- U.S. Patent No. 8,507,205, entitled “Single Cell Analysis by Polymerase Cycling Assembly”
- U.S. Patent No. 8,628,927, entitled “Monitoring Health and Disease Status Using Clonotype Profiles”
- U.S. Patent No. 8,685,898, entitled “Adaptive Immunity Profiling and Methods for Generation of Monoclonal Antibodies”
- U.S. Patent No. 8,691,510, entitled “Sequence Analysis of Complex Amplicons”
- U.S. Patent No. 8,748,103, entitled “Monitoring Health and Disease Status Using Clonotype Profiles”
- U.S. Patent No. 8,795,970, entitled “Methods of Monitoring Conditions by Sequence Analysis”
- U.S. Patent No. 9,043,160, entitled “Method of Determining Clonotypes and Clonotype Profiles”
- U.S. Patent No. 9,150,905, entitled “Compositions and Method for Measuring and Calibrating Amplification Bias in Multiplexed PCR Reactions”
- U.S. Patent No. 9,181,590, entitled “Quantification of Adaptive Immune Cell Genomes in a Complex Mixture Of Cells”
- U.S. Patent No. 9,181,591, entitled “Quantification of Adaptive Immune Cell Genomes in a Complex Mixture Of Cells”
- U.S. Patent No. 9,217,176 entitled “Methods of Monitoring Conditions by Sequence Analysis”
- U.S. Patent No. 9,228,232 entitled “Methods of Monitoring Conditions by Sequence Analysis”
- U.S. Patent No. 9,279,159 entitled “Quantification of Adaptive Immune Cell Genomes in a Complex Mixture of Cells”
- U.S. Patent No. 9,347,099 entitled “Single Cell Analysis by Polymerase Cycling Assembly”
- U.S. Patent No. 9,365,901 entitled “Monitoring Immunoglobulin Heavy Chain Evolution in B-cell Acute Lymphoblastic Leukemia”
- U.S. Patent No. 9,371,558 entitled “Compositions and Method for Measuring and Calibrating Amplification Bias in Multiplexed PCR Reactions”
- U.S. Patent No. 9,394,567 entitled “Detection and Quantification of Sample Contamination in Immune Repertoire Analysis”
- U.S. Patent No. 9,416,420 entitled “Monitoring Health and Disease Status Using Clonotype Profiles”
- U.S. Patent No. 9,499,865 entitled "Detection and Measurement of Tissue-Infiltrating Lymphocytes"
- U.S. Patent No. 9,506,119 entitled “Method of Sequence Determination Using Sequence Tags”
- U.S. Patent No. 9,512,487 entitled “Monitoring Health and Disease Status Using Clonotype Profiles”
- U.S. Patent No. 9,523,129 entitled "Sequence Analysis of Complex Amplicons"
- U.S. Patent No. 9,528,160 entitled "Rare Clonotypes and Uses Thereof"
OUR TRADEMARKS
The following trademarks are registered or pending marks owned by Adaptive Biotechnologies:
Adaptive Biotechnologies®, immunoSEQ®, clonoSEQ®, pairSEQ™, tilSEQ™, immuneACCESS™, amplify immunology™, amplify discovery™, amplify answers™, Adaptive Therapeutics™, TruTCR™, What gets measured gets managed™
Any unauthorized use is expressly prohibited.
All other trademarks are the property of their respective owners.